Periodic Reporting for period 1 - SPHERO-NASH (A novel NASH model for target and drug candidate identification)

Metabolic dysfunction-associated steatotic liver disease is an important global health burden that affects an estimated 1 billion individuals, or 25% of all adults worldwide. While initially benign, the condition can progress to metabolic dysfunction-associated steatohepatitis...